SEC Tracker
Get the app

Cencora COR

Cencora restructures reporting segments

Item 7.01 Investor disclosure

Form
8-K
Filed
Importance
Routine
  1. New reporting structure includes Pharmaceutical Distribution and Services, Specialty Pharmaceutical and Provider Services, and Other
  2. Reorganization affects U.S. and International Healthcare Solutions segments
  3. Exhibit 99.1 provides unaudited revised segment info for 2026 and 2025
  4. Other segment includes MWI Animal Health and parts of PharmaLex

Written from the 8-K on EDGAR. Check the filing before you rely on it.

Open in the appGet the appView on EDGAR

Get an email when Cencora files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 5122 and related industry codes: the same peer list as the financial tables.

  1. Cardinal Health CAH public float $48.2B, Dec 31, 2025
  2. McKesson MCK public float $95.3B, Sep 30, 2025
  3. Herbalife HLF public float $762M, Jun 30, 2025
  4. Nu Skin Enterprises NUS public float $390M, Jun 30, 2025
  5. DataMeds AI MEDS public float $27M, Jun 30, 2025